The life sciences industry enters 2024 with measured optimism, signaling that the sector has reverted to its long-term trend for growth. A flurry of recent announcements, from strong initial public offerings to exciting new mergers and acquisitions, has breathed new life into the industry.
Trends in Life Sciences
Expect both biotech and pharma research and development to continue to decode treatments and drugs for existing conditions, and in many cases, work together to achieve results. There is reason for optimism among startups, as significant dry powder exists. However, the lessons learned in 2023 still apply in 2024. Strong clinical trials, along with financial discipline, are key components to attract funding.
>>Access Trends in Life Sciences External Link
Leasing Market Fundamentals
Inventory growth has been a direct response to employment-fueled growth as markets raced to meet demand. A recalibration is currently underway while market fundamentals rebalance.
>>Access Leasing Market Fundamentals External Link
Labor
Life sciences labor market experienced some easing in 2023. Occupations that are high in demand remain difficult to fill.
>>Access Labor External Link
Global Funding
Global venture capital volume has fallen from pandemic-fueled highs, but 2024 could be the year that the dry powder sitting on the sidelines begins to be deployed in earnest.
>>Access Global Funding External Link
Clinical Trials Key Growth Driver
Drug trials continue to dominate the global clinical trials market. FDA approvals soared to a five-year high in 2023, helping to fuel demand for life sciences space and igniting investor enthusiasm.
>>Access Clinical Trials Key Growth Driver External Link
Emerging Markets
Discover trends in emerging markets, including inventory growth, inflows of private and public funding and employment growth.
>>Access Emerging Markets External Link
Europe
A spotlight on European life sciences markets and trends. The European life sciences sector is steadily maturing, as the hype of the pandemic passes and the tougher funding environment is absorbed.
>>Access Europe External Link
Select each city on the map below to view an in-depth life sciences market summary External Link .